News and Announcements
Proteomics International Advances Deals with Singapore and China Partners
- Published March 21, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Proteomics International Laboratories Ltd (ASX:PIQ) (PILL), the leader in predictive diagnostics for diabetic kidney disease, will advance deals with commercialisation partners in Singapore and China, which is patented in both countries, to the Asian market.
KEY TAKEAWAYS:
- PromarkerD technology has been validated by the peer-reviewed scientific journal EuPA Open Proteomics, the official journal of the European Proteomics Association (EuPA).
- Kidney disease is one of the major complications of diabetes and affects approximately one-third of all adult diabetics. Keeping people alive on dialysis costs more than $100,000 per person per year.
- Globally the diabetes epidemic cost health systems $673 billion dollars in 2015.
- Today there are 231 million people living with diabetes in Asia alone, according to the International Diabetes Federation.
- Worldwide this number is forecast to rise to 642 million people by 2040, and
- 214 million people are predicted to get chronic kidney disease as a result.
Frost & Sullivan states that novel tools like PromarkerD can allow “enhanced management of obesity, diabetes and related complications in the near future”. “If we can stem this health crisis tsunami by identifying and treating people before they are symptomatic we are saving lives, as well as billions of dollars in health costs,” said Dr Lipscombe.
PILL’s diagnostic research is made possible by the company’s proprietary biomarker discovery platform termed Promarker, which searches for protein ‘fingerprints’ in a sample. This disruptive technology can identify proteins that distinguish between people who have a disease and people who do not, using only a simple blood test. It is a powerful alternative to genetic testing.
Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Everything is now competing for the same dollar
Key takeaways As recently as 2022, Germany and Japan could borrow for 30 years at close to zero. That world is gone, and AI is now bidding for what is left. Over the past fortnight, I listened to founders, operators and allocators describe where their industries are heading. They covered four very different frontiers. Each […]
Australia has not held 90 days of fuel since 2012. The fix may start at a sewage plant.
A decommissioned council treatment site in Bundaberg is being built into a $188.9 million biorefinery. Its managing director is candid that the largest revenue line is not yet contracted. Australia has not met its international 90-day fuel reserve obligation since 2012. Around 90 per cent of the country’s liquid fuel is imported. Andy Whitmore, Managing […]
Backed By Leading Investment Groups and Family Offices
